Sick from a nasty stomach bug? Moderna's Norovirus vaccine might be the solution
Norovirus cases are significantly increasing in the US and Canada. Moderna is developing an mRNA-based vaccine, currently in Phase 3 clinical trials, with the potential to be the first approved Norovirus vaccine by 2026. Proper hand hygiene and surface disinfection remain crucial for prevention.
Norovirus cases are significantly increasing in the US and Canada. Moderna is developing an mRNA-based vaccine, currently in Phase 3 clinical trials, with the potential to be the first approved Norovirus vaccine by 2026. Proper hand hygiene and surface disinfection remain crucial for prevention.
